Benjamin Hall

More news - News 24 hours In a recent long-term research study published Tuesday, Eli Lilly reported that its popular weight-management drug significantly reduced the incidence of type 2 diabetes by 94 percent among overweight or obese adults who had prediabetic symptoms, compared to a control group that received a placebo. The late-stage study explored the effects of tirzepatide, the active compound in both Eli Lilly’s Zepbound weight-loss shot and the diabetes treatment Mounjaro. Over about three years, participants who received the highest weekly dose of tirzepatide experienced an average reduction in body weight of 22.9 percent, while those who…

Related media - Latest news As the WNBA regular season nears its climax, the competition for playoff spots intensifies. Every team is jockeying for position, with less than a month left to solidify their position. Here's an in-depth look at the current contenders, analyzing their strengths, potential weaknesses, and key challenges. New York Liberty: Keeping the Pace The Liberty have exceeded all expectations this season, echoing the Aces' previous dominance. Their primary concern is maintaining their stellar performance under the increasing pressure of the playoffs and effectively managing player fatigue. Minnesota Lynx: Needs Interior Score Known for their prowess from…

More news - Latest news MOSCOW, Russia — The Russian Revenue Service has officially designated the Clooney Foundation for Justice, an American nonprofit, as “undesirable.” This classification, which has been used against foreign organizations since 2015, accuses the foundation of engaging in activities that allegedly aim to discredit Russia. Founded by famed actor George Clooney and his wife, human rights lawyer Amal Clooney, the foundation has been active in advocating for justice globally. Russian authorities, however, say the foundation's operations mirror Hollywood-style tactics to undermine Moscow's image. According to a statement released via the Telegram messaging platform by the General…